2018
DOI: 10.1021/acs.langmuir.8b00114
|View full text |Cite
|
Sign up to set email alerts
|

Living Bacteria–Nanoparticle Hybrids Mediated through Surface-Displayed Peptides

Abstract: In this study, we investigated the preparation of living bacteria-nanoparticle hybrids mediated by surface-displayed peptides. The assembly of metallic nanoparticles on living bacteria has been achieved under mild conditions utilizing metal-peptide interactions, whereas the viability of the bacterial cells was greatly preserved. Escherichia coli was engineered with inducible gene circuits to control the display of peptides with desired sequences. Several designed peptide sequences as well as known gold-binding… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 25 publications
(23 citation statements)
references
References 52 publications
(95 reference statements)
0
23
0
Order By: Relevance
“…Another reason to first utilize gold as a target substrate is due to the availability of positive control microbial strains, since there are several previously identified microbes that show high selective affinity against gold. [ 16,41 ] In order to achieve successful biopanning of the eCPX 3.0 library against gold or ITO, the optimum shear stress condition was first investigated with four E. coli strains known to have different affinities toward gold. This condition was then used to isolate cells with novel peptide sequences that selectively bind to gold or to ITO from the bacterial display library.…”
Section: Introductionmentioning
confidence: 99%
“…Another reason to first utilize gold as a target substrate is due to the availability of positive control microbial strains, since there are several previously identified microbes that show high selective affinity against gold. [ 16,41 ] In order to achieve successful biopanning of the eCPX 3.0 library against gold or ITO, the optimum shear stress condition was first investigated with four E. coli strains known to have different affinities toward gold. This condition was then used to isolate cells with novel peptide sequences that selectively bind to gold or to ITO from the bacterial display library.…”
Section: Introductionmentioning
confidence: 99%
“…Gold-binding peptides were inserted at both termini. On the N terminal side, a variety of gold-binding peptides known from the literature [38][39][40] and listed in Figure 1C were incorporated after a CTSGQ linker, while on the C terminal side, the P2X peptide, a YPet-Mona binding motif with some affinity to gold, was used [17]. Variants of the eCPX scaffold are, therefore, available with and without each of N-terminal cysteine, additional N-terminal gold-binding sequences and C-terminal P2X.…”
Section: Resultsmentioning
confidence: 99%
“…For inducible bacterial peptide display by eCPX, MC1061 E. coli containing pDSJR plasmid (Cm R ) with P2X removed [17] (referred to as "no cys no P2X") or pB33-nl3 (Cm R ) with or without P2X [11,44] (referred to as "cys P2X" and "cys no P2X", respectively) were used. Both are pBad33-eCPX variants, with the pB33-nl3 having CTSGQ leading peptide at the N-terminal while pDSJR instead has GTSGQ; all peptides were inserted just after the N terminal of the pB33-nl3 with P2X ("cys P2X") and are therefore preceded by CTSGQ.…”
Section: Scaffolds and Cell Culturingmentioning
confidence: 99%
See 1 more Smart Citation
“…[2] Although these methodologies resulted in unstable therapeutic outcomes,t hese pioneering trials have ushered an ew era for microorganism-based tumor therapy.U pon elaborate fabrication and biological manipulation, various types of bacterial cells have been engineered to serve as delivery vectors for chemotherapeutics, [3] plasmids, [4] proteins [5] as well as other composite nanoplatforms for tumor therapies. [6] Such modifications may endow bacterial cells with diverse therapeutic functions,i ncluding Fenton nanocatalytic therapeutics, [7] photothermal eradication, [8] and biotherapy, [9] contributing to the next generation of tumor nanomedicine,t ermed microbiotic nanomedicine.…”
Section: Introductionmentioning
confidence: 99%